- 米国企業
- Acasti Pharma Inc.
Acasti Pharma Inc.ACST
時価総額
$2556.6万
PER
2020年 3月31日 | 2021年 3月31日 | 2022年 3月31日 | 2023年 3月31日 | |
Cash and cash equivalents | 14 | 51 | 30 | 28 |
Short-Term Investments | - | 10 | 13 | 0 |
Receivables | 1 | 1 | 1 | 1 |
Assets held for sale | - | 1 | 1 | - |
Prepaid expenses | 1 | 0 | 1 | 1 |
Total current assets | 16 | 62 | 46 | 29 |
Operating lease right of use asset | 0 | 0 | 0 | 0 |
Equipment | - | - | - | 0 |
Intangible assets | 4 | - | 70 | 41 |
Goodwill | - | - | 13 | 8 |
Total assets | 23 | 62 | 129 | 79 |
Trade and other payables | 7 | 1 | 3 | 3 |
Operating lease liability | 0 | 0 | 0 | 0 |
Total current liabilities | 7 | 2 | 3 | 3 |
Derivative warrant liabilities | 2 | 5 | 0 | - |
Operating lease liability | 0 | - | 0 | 0 |
Deferred tax liability | - | - | 17 | 7 |
Total liabilities | 10 | 7 | 20 | 11 |
Common Stock, Value, Issued | 137 | 197 | 258 | 258 |
Additional Paid in Capital | 10 | 11 | 12 | 14 |
Accumulated other comprehensive loss | -8 | -6 | -6 | -6 |
Accumulated deficit | -126 | -146 | -156 | -198 |
Total shareholder's equity | 13 | 56 | 108 | 68 |
Total liabilities and shareholders’ equity | 23 | 62 | 129 | 79 |